Indassc Pharma Private Limited
About Indassc Pharma Private Limited
Data last updated:
Indassc Pharma Private Limited is a private limited company based in Bidupur, Bihar, India. It was incorporated on 27 July 2023.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U46497BR2023PTC064361.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nirmal Kumar and Sujata Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bidupur, Bihar.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.45 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹16,310 (net margin -11.3%) and EBITDA of -₹13,088 (EBITDA margin -9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Ram Parvesh Chaudhary, Panch – Majhauli Vill, Bidupur, Bihar, India – 844502
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Indassc Pharma Private Limited
The main business activity of Indassc Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Indassc Pharma Private Limited FY 2025 filings available
Indassc Pharma Private Limited reported revenue of ₹1.45 Lakh (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Indassc Pharma Private Limited
Revenue fell 7% in the latest year. EBITDA fell 379% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Indassc Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹13,088 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹16,310 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Indassc Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -9% | •••• |
| Net Profit Margin | -11.3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indassc Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Indassc Pharma Private Limited
Indassc Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Naturegrace Impex Private Limited | ₹1.47 Lakh (FY 2025) | •••• | •••• | -57.0% | •••• | Delhi, India |
| Rathi Indore Steels Private Limited | ₹1.46 Lakh (FY 2024) | •••• | •••• | 241.0% | •••• | New Delhi, Delhi, India |
| Arinjay Pharmaceuticals Private Limited | ₹1.45 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Alibag, Maharashtra, India |
| Protishruti Foods & Hygiene Care Private Limited | ₹1.45 Lakh (FY 2025) | •••• | •••• | 325.0% | •••• | Kolkata, West Bengal, India |
| Shinkolite Pvt Ltd | ₹1.45 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | New Delhi, Delhi, India |
| Indassc Pharma Private Limited this company | ₹1.45 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Bidupur, Bihar, India |
| Sankat Mochan Commerce Pvt.Ltd. | ₹1.45 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Indigra Exports Private Limited. | ₹1.44 Lakh (FY 2024) | •••• | •••• | -97.0% | •••• | Bangalore, Karnataka, India |
| Hma Investment and Trading Private Limited | ₹1.44 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Midos Laboratory India Private Limited | ₹1.44 Lakh (FY 2024) | •••• | •••• | -26.0% | •••• | New Delhi, Delhi, India |
| Carbon Blue Agro Products Private Limited | ₹1.43 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Namakkal, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Indassc Pharma by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Indassc Pharma Private Limited
Indassc Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmal Kumar | Director | 27 Jul 2023 | 3 Years 2 Months | Current |
| Sujata Kumari | Director | 27 Jul 2023 | 3 Years 2 Months | Current |
Charges & Borrowings of Indassc Pharma Private Limited
Indassc Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Indassc Pharma Private Limited
Employment history and EPFO contributions of people linked to Indassc Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indassc Pharma Private Limited
Indassc Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Nirmal Kumar was appointed as Director on 27 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Indassc Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indassc Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indassc Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indassc Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indassc Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indassc Pharma Private Limited
Indassc Pharma is an active private limited company based in Bidupur, Bihar, India. It was incorporated on 27 July 2023 (3+ years old) and is registered under CIN U46497BR2023PTC064361.
Indassc Pharma reported revenue of ₹1.45 Lakh for FY 2025 (down 7% YoY).
Indassc Pharma has 2 current directors:
- Nirmal Kumar - Director
- Sujata Kumari - Director
Indassc Pharma reported a net loss of ₹16,310 (net margin -11.3%) and EBITDA of -₹13,088 (EBITDA margin -9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Indassc Pharma is U46497BR2023PTC064361. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indassc Pharma was incorporated on 27 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Indassc Pharma by revenue are Naturegrace Impex Private Limited, Rathi Indore Steels Private Limited, Arinjay Pharmaceuticals Private Limited, Protishruti Foods & Hygiene Care Private Limited, Shinkolite Pvt Ltd and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Nirmal Kumar was appointed as Director on 27 Jul 2023. Sujata Kumari was appointed as Director on 27 Jul 2023.
The registered office of Indassc Pharma is at CO Ram Parvesh Chaudhary, Panch – Majhauli Vill, Bidupur, Bihar, India – 844502.
Indassc Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
No. Indassc Pharma is not listed on any stock exchange. It is an unlisted company.